APO RESEARCH · REPORT
Androstenedione
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Product & engineering
Understand the product.
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
Selected research
Industry Research
Androstenedione Industry Research Report 2026
Market perspective
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
Read the full market overview
In the report, the data bases on androstenedione and androstadienedione.
Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.
China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.
Report Scope
This report quantifies the global Androstenedione market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Androstenedione Market by Company
BIOVET
Indo Phyto Chemicals
Sito Bio
Goto Pharmaceutical
Tianjin King York
Jiufu
Yongning Pharma
Jiangxi Hongyuan Pharmaceutical
Kaizon
Xi’an Gaoyuan Bio-Chem
Dongyao Pharmaceutical
Huazhong Pharmaceutical
Darui
Danjiangkou Danao
Dahua Pharmaceutical
Androstenedione Segment by Type
Androstenedione
Androstadienedione
Androstenedione Segment by Application
Arthritis Pharmaceuticals
Fertility Control Pharmaceuticals
Infectious Inflammation Pharmaceuticals
Others
Androstenedione Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androstenedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Androstenedione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androstenedione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Androstenedione manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Androstenedione by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Androstenedione in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Androstenedione
- Androstadienedione
Applications
- Arthritis Pharmaceuticals
- Fertility Control Pharmaceuticals
- Infectious Inflammation Pharmaceuticals
- Others
Companies covered
- BIOVET
- Indo Phyto Chemicals
- Sito Bio
- Goto Pharmaceutical
- Tianjin King York
- Jiufu
- Yongning Pharma
- Jiangxi Hongyuan Pharmaceutical
- Kaizon
- Xi’an Gaoyuan Bio-Chem
- Dongyao Pharmaceutical
- Huazhong Pharmaceutical
- Darui
- Danjiangkou Danao
- Dahua Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Androstenedione Market Size (2021-2032)
- 2.2.2 Global Androstenedione Sales (2021-2032)
- 2.2.3 Global Androstenedione Market Average Price (2021-2032)
- 2.3 Androstenedione by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Androstenedione
- 2.3.3 Androstadienedione
- 2.4 Androstenedione by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Arthritis Pharmaceuticals
- 2.4.3 Fertility Control Pharmaceuticals
- 2.4.4 Infectious Inflammation Pharmaceuticals
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Androstenedione Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Androstenedione Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Androstenedione Revenue of Manufacturers (2021-2026)
- 3.4 Global Androstenedione Average Price by Manufacturers (2021-2026)
- 3.5 Global Androstenedione Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Androstenedione, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Androstenedione, Product Type & Application
- 3.8 Global Manufacturers of Androstenedione, Established Date
- 3.9 Global Androstenedione Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BIOVET
- 4.1.1 BIOVET Company Information
- 4.1.2 BIOVET Business Overview
- 4.1.3 BIOVET Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BIOVET Androstenedione Product Portfolio
- 4.1.5 BIOVET Recent Developments
- 4.2 Indo Phyto Chemicals
- 4.2.1 Indo Phyto Chemicals Company Information
- 4.2.2 Indo Phyto Chemicals Business Overview
- 4.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
- 4.2.5 Indo Phyto Chemicals Recent Developments
- 4.3 Sito Bio
- 4.3.1 Sito Bio Company Information
- 4.3.2 Sito Bio Business Overview
- 4.3.3 Sito Bio Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sito Bio Androstenedione Product Portfolio
- 4.3.5 Sito Bio Recent Developments
- 4.4 Goto Pharmaceutical
- 4.4.1 Goto Pharmaceutical Company Information
- 4.4.2 Goto Pharmaceutical Business Overview
- 4.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
- 4.4.5 Goto Pharmaceutical Recent Developments
- 4.5 Tianjin King York
- 4.5.1 Tianjin King York Company Information
- 4.5.2 Tianjin King York Business Overview
- 4.5.3 Tianjin King York Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tianjin King York Androstenedione Product Portfolio
- 4.5.5 Tianjin King York Recent Developments
- 4.6 Jiufu
- 4.6.1 Jiufu Company Information
- 4.6.2 Jiufu Business Overview
- 4.6.3 Jiufu Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiufu Androstenedione Product Portfolio
- 4.6.5 Jiufu Recent Developments
- 4.7 Yongning Pharma
- 4.7.1 Yongning Pharma Company Information
- 4.7.2 Yongning Pharma Business Overview
- 4.7.3 Yongning Pharma Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yongning Pharma Androstenedione Product Portfolio
- 4.7.5 Yongning Pharma Recent Developments
- 4.8 Jiangxi Hongyuan Pharmaceutical
- 4.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
- 4.8.2 Jiangxi Hongyuan Pharmaceutical Business Overview
- 4.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
- 4.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments
- 4.9 Kaizon
- 4.9.1 Kaizon Company Information
- 4.9.2 Kaizon Business Overview
- 4.9.3 Kaizon Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Kaizon Androstenedione Product Portfolio
- 4.9.5 Kaizon Recent Developments
- 4.10 Xi’an Gaoyuan Bio-Chem
- 4.10.1 Xi’an Gaoyuan Bio-Chem Company Information
- 4.10.2 Xi’an Gaoyuan Bio-Chem Business Overview
- 4.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
- 4.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments
- 4.11 Dongyao Pharmaceutical
- 4.11.1 Dongyao Pharmaceutical Company Information
- 4.11.2 Dongyao Pharmaceutical Business Overview
- 4.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
- 4.11.5 Dongyao Pharmaceutical Recent Developments
- 4.12 Huazhong Pharmaceutical
- 4.12.1 Huazhong Pharmaceutical Company Information
- 4.12.2 Huazhong Pharmaceutical Business Overview
- 4.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
- 4.12.5 Huazhong Pharmaceutical Recent Developments
- 4.13 Darui
- 4.13.1 Darui Company Information
- 4.13.2 Darui Business Overview
- 4.13.3 Darui Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Darui Androstenedione Product Portfolio
- 4.13.5 Darui Recent Developments
- 4.14 Danjiangkou Danao
- 4.14.1 Danjiangkou Danao Company Information
- 4.14.2 Danjiangkou Danao Business Overview
- 4.14.3 Danjiangkou Danao Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Danjiangkou Danao Androstenedione Product Portfolio
- 4.14.5 Danjiangkou Danao Recent Developments
- 4.15 Dahua Pharmaceutical
- 4.15.1 Dahua Pharmaceutical Company Information
- 4.15.2 Dahua Pharmaceutical Business Overview
- 4.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
- 4.15.5 Dahua Pharmaceutical Recent Developments
5 Global Androstenedione Market Scenario by Region
- 5.1 Global Androstenedione Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Androstenedione Sales by Region: 2021-2032
- 5.2.1 Global Androstenedione Sales by Region: 2021-2026
- 5.2.2 Global Androstenedione Sales by Region: 2027-2032
- 5.3 Global Androstenedione Revenue by Region: 2021-2032
- 5.3.1 Global Androstenedione Revenue by Region: 2021-2026
- 5.3.2 Global Androstenedione Revenue by Region: 2027-2032
- 5.4 North America Androstenedione Market Facts & Figures by Country
- 5.4.1 North America Androstenedione Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Androstenedione Sales by Country (2021-2032)
- 5.4.3 North America Androstenedione Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Androstenedione Market Facts & Figures by Country
- 5.5.1 Europe Androstenedione Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Androstenedione Sales by Country (2021-2032)
- 5.5.3 Europe Androstenedione Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Androstenedione Market Facts & Figures by Country
- 5.6.1 Asia Pacific Androstenedione Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Androstenedione Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Androstenedione Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Androstenedione Market Facts & Figures by Country
- 5.7.1 South America Androstenedione Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Androstenedione Sales by Country (2021-2032)
- 5.7.3 South America Androstenedione Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Androstenedione Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Androstenedione Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Androstenedione Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Androstenedione Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Androstenedione Sales by Type (2021-2032)
- 6.1.1 Global Androstenedione Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Androstenedione Sales Market Share by Type (2021-2032)
- 6.2 Global Androstenedione Revenue by Type (2021-2032)
- 6.2.1 Global Androstenedione Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Androstenedione Revenue Market Share by Type (2021-2032)
- 6.3 Global Androstenedione Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Androstenedione Sales by Application (2021-2032)
- 7.1.1 Global Androstenedione Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Androstenedione Sales Market Share by Application (2021-2032)
- 7.2 Global Androstenedione Revenue by Application (2021-2032)
- 7.2.1 Global Androstenedione Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Androstenedione Revenue Market Share by Application (2021-2032)
- 7.3 Global Androstenedione Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Androstenedione Value Chain Analysis
- 8.1.1 Androstenedione Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Androstenedione Production Mode & Process
- 8.2 Androstenedione Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Androstenedione Distributors
- 8.2.3 Androstenedione Customers
9 Global Androstenedione Analyzing Market Dynamics
- 9.1 Androstenedione Industry Trends
- 9.2 Androstenedione Industry Drivers
- 9.3 Androstenedione Industry Opportunities and Challenges
- 9.4 Androstenedione Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst